MeVis Medical Solutions AG (LTS:0HI7) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0HI7 MeVis Medical Solutions AG LTS:0HI7
70 GF Score
Price €23.40
GF Value €23.10
! 5 Warning Signs
View Full Analysis

What is MeVis Medical Solutions AG Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

LTS:0HI7
70GF Score
MeVis Medical Solutions AG LTS:0HI7
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is MeVis Medical Solutions AG (LTS:0HI7) Overvalued in 2026?

Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued. The current stock price of €23.40 is trading 1.3% above its estimated GF Value™ of €23.10.

Key valuation signals for LTS:0HI7:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €23.10 vs. price of €23.40 (1.3% above fair value)
  • GF Score™: 70/100 with 5 warning signs

No single metric tells the full story. See the LTS:0HI7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MeVis Medical Solutions AG Business Description

Other Exchanges M3V:Germany
Address Caroline-Herschel-Strasse 1, Bremen, DEU, 28359
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
70GF Score

Get the complete analysis for LTS:0HI7

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€23.40
Price
€23.10
GF Value